|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.65 INR | +1.22% |
|
-3.56% | -39.98% |
| Market Cap | 180.66Cr 1.91Cr 1.68Cr 1.54Cr 1.45Cr 2.71Cr 2.75Cr 19Cr 7.18Cr 89Cr 7.16Cr 7.01Cr 308.09Cr | P/E 2024 |
137x | P/E 2025 | -4.53x |
|---|---|---|---|---|---|
| Enterprise Value | 742.93Cr 7.84Cr 6.89Cr 6.35Cr 5.94Cr 11Cr 11Cr 76Cr 30Cr 364.52Cr 29Cr 29Cr 1.27TCr | EV / Sales 2024 |
0.77x | EV / Sales 2025 | 0.64x |
| Free-Float |
42.77% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +1.22% | ||
| 1 week | -3.56% | ||
| Current month | -6.43% | ||
| 1 month | -4.12% | ||
| 3 months | +11.70% | ||
| 6 months | -44.89% | ||
| Current year | -39.98% |
| 1 week | 11.25 | 12.24 | |
| 1 month | 11.05 | 12.75 | |
| Current year | 9.3 | 20.9 | |
| 1 year | 9.3 | 23.87 | |
| 3 years | 9.3 | 56.5 | |
| 5 years | 9.3 | 56.5 | |
| 10 years | 7.1 | 56.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sushil Kapoor
DFI | Director of Finance/CFO | 68 | 14/11/2022 |
| Compliance Officer | - | 01/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Sanjiv Goyal
CHM | Chairman | 66 | 27/06/1995 |
Rupinder Tewari
BRD | Director/Board Member | 69 | 11/02/2019 |
| Director/Board Member | 75 | 21/09/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 19/24/19 | Buy | 4,00,000 | 0.1784% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.22% | -3.56% | -44.76% | -38.03% | 2.36Cr | ||
| +0.44% | +3.07% | +12.91% | +88.58% | 4.73TCr | ||
| +1.49% | +2.84% | +53.64% | +102.01% | 3.49TCr | ||
| +0.85% | +6.97% | -3.82% | +41.40% | 1.22TCr | ||
| -0.85% | +3.91% | +14.34% | +96.32% | 1.18TCr | ||
| +1.52% | -0.57% | +37.80% | +122.46% | 888.11Cr | ||
| +0.59% | +0.17% | +16.96% | +41.10% | 696.37Cr | ||
| +0.90% | +4.47% | +50.50% | -12.96% | 677.48Cr | ||
| -0.14% | +1.80% | +29.23% | +237.02% | 649.25Cr | ||
| +0.71% | +2.14% | -35.63% | +0.19% | 509.06Cr | ||
| Average | +0.67% | +1.97% | +13.12% | +67.81% | 1.4TCr | |
| Weighted average by Cap. | +0.71% | +3.08% | +24.27% | +86.99% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.68TCr 18Cr 16Cr 14Cr 13Cr 25Cr 26Cr 172.85Cr 67Cr 826.53Cr 67Cr 65Cr 2.87TCr | 1.67TCr 18Cr 15Cr 14Cr 13Cr 25Cr 25Cr 171.39Cr 66Cr 819.56Cr 66Cr 65Cr 2.85TCr |
| Net income | 5Cr 5L 5L 4L 4L 7L 8L 51.25L 19.84L 2.45Cr 19.79L 19.37L 8.52Cr | -113.68Cr -1.2Cr -1.05Cr -97.14L -90.94L -1.7Cr -1.73Cr -12Cr -4.52Cr -56Cr -4.51Cr -4.41Cr -193.86Cr |
| Net Debt | 615.24Cr 6.49Cr 5.71Cr 5.26Cr 4.92Cr 9.22Cr 9.38Cr 63Cr 24Cr 301.86Cr 24Cr 24Cr 1.05TCr | 562.27Cr 5.94Cr 5.21Cr 4.8Cr 4.5Cr 8.43Cr 8.57Cr 58Cr 22Cr 275.88Cr 22Cr 22Cr 958.85Cr |
Employees
1,786
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/26/24 | ₹11.65 | +1.22% | 69,139 |
| 23/26/23 | ₹11.51 | -2.62% | 1,36,920 |
| 22/26/22 | ₹11.82 | +3.32% | 2,33,443 |
| 19/26/19 | ₹11.44 | -1.63% | 1,31,033 |
| 18/26/18 | ₹11.63 | -3.73% | 6,11,867 |
- Stock Market
- Stocks
- NECLIFE Stock
Select your edition
All financial news and data tailored to specific country editions
















